Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
1 - 12 of 90 Results
Sort by:
Best Match
Literature - Publication Review
60 second spotlight: prenatal screening for autosomal trisomies
Quick summary of a prospective 2-center study of 862 twin pregnancies. Compared no-call rate and performance against 16,382 singleton pregnancies.
Flyer
Vanadis NIPT system - Flyer for Patients
Explains the fundamentals of Vanadis NIPT, including how the test works, the conditions tested, the time it can be performed, and the benefits of the screening test.
Brochure
Vanadis NIPT system
Outlines differentiating features of the Vanadis NIPT system, inclusive of minimal hands-on time, walkaway automation, high precision and no PCR or sequencing. Empowering any laboratory to conduct NIPT in-house.
Brochure
Vanadis cfDNA platform
Highlights the defining features behind the Vanadis cfDNA platform, including its ease of use, full automation, high precision and no PCR or sequencing required. Now any lab can conduct cfDNA analysis in-house.
Flyer
Vanadis cfDNA platform - Flyer for Laboratories
Flyer that hightlights the Vanadis cfDNA platform, built for all laboratories.
Flyer
Vanadis NIPT system - Flyer for Providers
Communicates the key strengths and features behind the Vanadis NIPT system, inclusive of high precision, no sequencing, no PCR, improved detection rate, minimal invasive procedures and no-call results.
Flyer
Revvity Transcribe AI
Revvity Transcribe AI, is an innovative OCR service designed to convert handwritten text on test request forms into a digitized format
Application Note
Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.
Application Note
Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy
Literature - Publication Review
Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.
Whitepaper
Overcoming hurdles in high-throughput profiling of cancer cell responses
Presenting case studies on how functional genomic screening is used to find therapeutic targets, identify patient populations, uncover MoA, investigate drug combinations, and reveal drug resistance and sensitivity
Whitepaper
CRISPR-Cas9 screening: a powerful approach to advance drug discovery
Find out about the potential of CRISPR-Cas9 screening for drug discovery in this white paper.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.